Association Between Lifestyle Factors, Vitamin and Garlic Supplementation, and Gastric Cancer Outcomes: A Secondary Analysis of a Randomized Clinical Trial

Yang Guo, Zhe-Xuan Li, Jing-Yu Zhang, Jun-Ling Ma, Lian Zhang, Yang Zhang, Tong Zhou, Wei-Dong Liu, Zhong-Xiang Han, Wen-Qing Li, Kai-Feng Pan, Wei-Cheng You, Yang Guo, Zhe-Xuan Li, Jing-Yu Zhang, Jun-Ling Ma, Lian Zhang, Yang Zhang, Tong Zhou, Wei-Dong Liu, Zhong-Xiang Han, Wen-Qing Li, Kai-Feng Pan, Wei-Cheng You

Abstract

Importance: The associations of lifestyle factors with gastric cancer (GC) are still underexplored in populations in China. Long-term nutritional supplementation may prevent GC in high-risk populations, but the possible effect modification by lifestyle factors remains unknown.

Objective: To evaluate how lifestyle factors, including smoking, alcohol intake, and diet, may change the risk of GC incidence and mortality and whether the effects of vitamin and garlic supplementation on GC are associated with major lifestyle factors.

Design, setting, and participants: This is a secondary analysis of the Shandong Intervention Trial, a masked, randomized, placebo-controlled trial that aimed to assess the effect of vitamin and garlic supplementations and Helicobacter pylori treatment on GC in a factorial design with 22.3 years of follow-up. The study took place in Linqu County, Shandong province, China, a high-risk area for GC. Data were collected from Jully 1995 to December 2017. Overall, 3365 participants aged 35 to 64 years identified in 13 randomly selected villages who agreed to undergo gastroscopy were invited to participate in the trial and were included in the analysis. Data analysis was conducted from March to May 2019.

Interventions: Participants received vitamin and garlic supplementation for 7.3 years, H pylori treatment for 2 weeks (among participants with H pylori ), or placebo.

Main outcomes and measures: The primary outcomes were GC incidence and GC mortality (1995-2017). We also examined the progression of gastric lesions (1995-2003) as a secondary outcome.

Results: Of the 3365 participants (mean [SD] age, 47.1 [9.2] years; 1639 [48.7%] women), 1677 (49.8%) were randomized to receive active vitamin supplementation, with 1688 (50.2%) receiving placebo, and 1678 (49.9%) receiving active garlic supplementation, with 1687 (50.1%) receiving placebo. Overall, 151 GC cases (4.5%) and 94 GC deaths (2.8%) were identified. Smoking was associated with increased risk of GC incidence (odds ratio, 1.72; 95% CI, 1.003-2.93) and mortality (hazard ratio [HR], 2.01; 95% CI, 1.01-3.98). Smoking was not associated with changes to the effects of vitamin or garlic supplementation. The protective effect on GC mortality associated with garlic supplementation was observed only among those not drinking alcohol (never drank alcohol: HR, 0.33; 95% CI, 0.15-0.75; ever drank alcohol: HR, 0.92; 95% CI, 0.55-1.54; P for interaction = .03), and significant interactions were only seen among participants with H pylori (never drank alcohol: HR, 0.31; 95% CI, 0.12-0.78; ever drank alcohol: HR, 0.91; 95% CI, 0.52-1.60; P for interaction = .04). No significant interactions between vitamin supplementation and lifestyle factors were found.

Conclusions and relevance: In this secondary analysis of a randomized clinical trial, smoking was associated with an increased risk of GC incidence and mortality. Not drinking alcohol was associated with a stronger beneficial effect of garlic supplementation on GC prevention. Our findings provide new insights into lifestyle intervention for GC prevention, suggesting that mass GC prevention strategies may need to be tailored to specific population subgroups to maximize the potential beneficial effect.

Trial registration: ClinicalTrials.gov Identifier: NCT00339768.

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Figures

Figure 1.. Study Flow Diagram
Figure 1.. Study Flow Diagram
Figure 2.. Associations Between Lifestyle Factors and…
Figure 2.. Associations Between Lifestyle Factors and Gastric Cancer Incidence and Mortality
HR indicates hazard ratio; OR, odds ratio. aLogistic regression adjusted for baseline histology, age, sex, history of ever using alcohol, history of ever smoking, vitamin supplementation (treatment or placebo), garlic supplementation (treatment or placebo), and H pylori treatment (H pylori treatment, placebo, or no H pylori). bEver smoking vs never smoking. cEver using alcohol vs never using alcohol. dConsuming at least 225 kg/y vs less than 225 kg/y (levels correspond to median distribution of intake between the 2 groups). eConsuming at least 8 kg/y vs less than 8 kg/y (levels correspond to median distribution of intake between the 2 groups). fConsuming at least 92 kg/y vs less than 92 kg/y (levels correspond to median distribution of intake between the 2 groups). gConsuming at least 81 kg/y vs less than 81 kg/y (levels correspond to median distribution of intake between the 2 groups). hCox regression adjusted for baseline histology, age, sex, history of ever using alcohol, history of ever smoking, vitamin supplementation (treatment or placebo), garlic supplementation (treatment or placebo), and H pylori treatment (H pylori treatment, placebo, or no H pylori).

References

    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. doi:10.3322/caac.21492
    1. You WC, Blot WJ, Li JY, et al. . Precancerous gastric lesions in a population at high risk of stomach cancer. Cancer Res. 1993;53(6):1317-1321.
    1. You WC, Blot WJ, Chang YS, et al. . Diet and high risk of stomach cancer in Shandong, China. Cancer Res. 1988;48(12):3518-3523.
    1. Kneller RW, You WC, Chang YS, et al. . Cigarette smoking and other risk factors for progression of precancerous stomach lesions. J Natl Cancer Inst. 1992;84(16):1261-1266. doi:10.1093/jnci/84.16.1261
    1. You WC, Blot WJ, Chang YS, et al. . Allium vegetables and reduced risk of stomach cancer. J Natl Cancer Inst. 1989;81(2):162-164. doi:10.1093/jnci/81.2.162
    1. Gail MH, You WC, Chang YS, et al. . Factorial trial of three interventions to reduce the progression of precancerous gastric lesions in Shandong, China: design issues and initial data. Control Clin Trials. 1998;19(4):352-369. doi:10.1016/S0197-2456(98)00016-6
    1. You WC, Brown LM, Zhang L, et al. . Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst. 2006;98(14):974-983. doi:10.1093/jnci/djj264
    1. Ma JL, Zhang L, Brown LM, et al. . Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst. 2012;104(6):488-492. doi:10.1093/jnci/djs003
    1. Li WQ, Ma JL, Zhang L, et al. . Effects of Helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups. J Natl Cancer Inst. 2014;106(7):dju116. doi:10.1093/jnci/dju116
    1. Li W-Q, Zhang J-Y, Ma J-L, et al. . Effects of Helicobacter pylori treatment and vitamin and garlic supplementation on gastric cancer incidence and mortality: follow-up of a randomized intervention trial. BMJ. 2019;366:l5016. doi:10.1136/bmj.l5016
    1. Vogtmann E, Flores R, Yu G, et al. . Association between tobacco use and the upper gastrointestinal microbiome among Chinese men. Cancer Causes Control. 2015;26(4):581-588. doi:10.1007/s10552-015-0535-2
    1. Qamar N, Castano D, Patt C, Chu T, Cottrell J, Chang SL. Meta-analysis of alcohol induced gut dysbiosis and the resulting behavioral impact. Behav Brain Res. 2019;376:112196. doi:10.1016/j.bbr.2019.112196
    1. Valdes AM, Walter J, Segal E, Spector TD. Role of the gut microbiota in nutrition and health. BMJ. 2018;361:k2179. doi:10.1136/bmj.k2179
    1. Capurso G, Lahner E. The interaction between smoking, alcohol and the gut microbiome. Best Pract Res Clin Gastroenterol. 2017;31(5):579-588. doi:10.1016/j.bpg.2017.10.006
    1. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet. 2001;357(9263):1191-1194. doi:10.1016/S0140-6736(00)04337-3
    1. You WC, Li JY, Blot WJ, et al. . Evolution of precancerous lesions in a rural Chinese population at high risk of gastric cancer. Int J Cancer. 1999;83(5):615-619. doi:10.1002/(SICI)1097-0215(19991126)83:5<615::AID-IJC8>;2-L
    1. Steevens J, Schouten LJ, Goldbohm RA, van den Brandt PA. Alcohol consumption, cigarette smoking, and risk of subtypes of oesophageal and gastric cancer: a prospective cohort study. Gut. 2010;59(1):39-48. doi:10.1136/gut.2009.191080
    1. Sjödahl K, Lu Y, Nilsen TI, et al. . Smoking and alcohol drinking in relation to risk of gastric cancer: a population-based, prospective cohort study. Int J Cancer. 2007;120(1):128-132. doi:10.1002/ijc.22157
    1. Freedman ND, Abnet CC, Leitzmann MF, et al. . A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes. Am J Epidemiol. 2007;165(12):1424-1433. doi:10.1093/aje/kwm051
    1. Tramacere I, Negri E, Pelucchi C, et al. . A meta-analysis on alcohol drinking and gastric cancer risk. Ann Oncol. 2012;23(1):28-36. doi:10.1093/annonc/mdr135
    1. Rota M, Pelucchi C, Bertuccio P, et al. . Alcohol consumption and gastric cancer risk: a pooled analysis within the StoP project consortium. Int J Cancer. 2017;141(10):1950-1962. doi:10.1002/ijc.30891
    1. Tramacere I, Pelucchi C, Bagnardi V, et al. . A meta-analysis on alcohol drinking and esophageal and gastric cardia adenocarcinoma risk. Ann Oncol. 2012;23(2):287-297. doi:10.1093/annonc/mdr136
    1. Wang S, Freedman ND, Loftfield E, Hua X, Abnet CC. Alcohol consumption and risk of gastric cardia adenocarcinoma and gastric noncardia adenocarcinoma: a 16-year prospective analysis from the NIH-AARP diet and health cohort. Int J Cancer. 2018;143(11):2749-2757. doi:10.1002/ijc.31740
    1. Tran GD, Sun XD, Abnet CC, et al. . Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer. 2005;113(3):456-463. doi:10.1002/ijc.20616
    1. Gao Y, Hu N, Han XY, et al. . Risk factors for esophageal and gastric cancers in Shanxi Province, China: a case-control study. Cancer Epidemiol. 2011;35(6):e91-e99. doi:10.1016/j.canep.2011.06.006
    1. Jakszyn P, Bingham S, Pera G, et al. . Endogenous versus exogenous exposure to N-nitroso compounds and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST) study. Carcinogenesis. 2006;27(7):1497-1501. doi:10.1093/carcin/bgl019
    1. Ma SH, Jung W, Weiderpass E, et al. . Impact of alcohol drinking on gastric cancer development according to Helicobacter pylori infection status. Br J Cancer. 2015;113(9):1381-1388. doi:10.1038/bjc.2015.333
    1. Shimazu T, Wakai K, Tamakoshi A, et al. ; Research Group for the Development and Evaluation of Cancer Prevention Strategies in Japan . Association of vegetable and fruit intake with gastric cancer risk among Japanese: a pooled analysis of four cohort studies. Ann Oncol. 2014;25(6):1228-1233. doi:10.1093/annonc/mdu115
    1. Jeurnink SM, Büchner FL, Bueno-de-Mesquita HB, et al. . Variety in vegetable and fruit consumption and the risk of gastric and esophageal cancer in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2012;131(6):E963-E973. doi:10.1002/ijc.27517
    1. Gonzalez CA, Lujan-Barroso L, Bueno-de-Mesquita HB, et al. . Fruit and vegetable intake and the risk of gastric adenocarcinoma: a reanalysis of the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST) study after a longer follow-up. Int J Cancer. 2012;131(12):2910-2919. doi:10.1002/ijc.27565
    1. Steevens J, Schouten LJ, Goldbohm RA, van den Brandt PA. Vegetables and fruits consumption and risk of esophageal and gastric cancer subtypes in the Netherlands Cohort Study. Int J Cancer. 2011;129(11):2681-2693. doi:10.1002/ijc.25928
    1. González CA, Pera G, Agudo A, et al. . Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Int J Cancer. 2006;118(10):2559-2566. doi:10.1002/ijc.21678
    1. Milner JA. A historical perspective on garlic and cancer. J Nutr. 2001;131(3s):1027S-1031S. doi:10.1093/jn/131.3.1027S
    1. Lee IC, Baek HS, Kim SH, et al. . Effect of diallyl disulfide on acute gastric mucosal damage induced by alcohol in rats. Hum Exp Toxicol. 2015;34(3):227-239. doi:10.1177/0960327114537095
    1. Jin ZY, Wallar G, Zhou JY, et al. . Consumption of garlic and its interactions with tobacco smoking and alcohol drinking on esophageal cancer in a Chinese population. Eur J Cancer Prev. 2019;28(4):278-286. doi:10.1097/CEJ.0000000000000456
    1. Zeng T, Zhang CL, Song FY, et al. . The activation of HO-1/Nrf-2 contributes to the protective effects of diallyl disulfide (DADS) against ethanol-induced oxidative stress. Biochim Biophys Acta. 2013;1830(10):4848-4859. doi:10.1016/j.bbagen.2013.06.028
    1. Khosla P, Karan RS, Bhargava VK. Effect of garlic oil on ethanol induced gastric ulcers in rats. Phytother Res. 2004;18(1):87-91. doi:10.1002/ptr.1349
    1. Ferreira RM, Pereira-Marques J, Pinto-Ribeiro I, et al. . Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota. Gut. 2018;67(2):226-236. doi:10.1136/gutjnl-2017-314205
    1. Coker OO, Dai Z, Nie Y, et al. . Mucosal microbiome dysbiosis in gastric carcinogenesis. Gut. 2018;67(6):1024-1032. doi:10.1136/gutjnl-2017-314281
    1. Chen K, Xie K, Liu Z, et al. . Preventive effects and mechanisms of garlic on dyslipidemia and gut microbiome dysbiosis. Nutrients. 2019;11(6):E1225. doi:10.3390/nu11061225
    1. Sezikli M, Çetinkaya ZA, Güzelbulut F, et al. . Effects of alpha tocopherol and ascorbic acid on Helicobacter pylori colonization and the severity of gastric inflammation. Helicobacter. 2012;17(2):127-132. doi:10.1111/j.1523-5378.2011.00925.x
    1. You WC, Zhang L, Gail MH, et al. . Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors. J Natl Cancer Inst. 2000;92(19):1607-1612. doi:10.1093/jnci/92.19.1607
    1. Lam TK, Freedman ND, Fan JH, et al. . Prediagnostic plasma vitamin C and risk of gastric adenocarcinoma and esophageal squamous cell carcinoma in a Chinese population. Am J Clin Nutr. 2013;98(5):1289-1297. doi:10.3945/ajcn.113.061267
    1. Gonzalez CA, Riboli E. Diet and cancer prevention: contributions from the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Eur J Cancer. 2010;46(14):2555-2562. doi:10.1016/j.ejca.2010.07.025
    1. Woodward M, Tunstall-Pedoe H, McColl K. Helicobacter pylori infection reduces systemic availability of dietary vitamin C. Eur J Gastroenterol Hepatol. 2001;13(3):233-237. doi:10.1097/00042737-200103000-00003
    1. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process: First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992;52(24):6735-6740.
    1. Pan KF, Zhang L, Gerhard M, et al. . A large randomised controlled intervention trial to prevent gastric cancer by eradication of Helicobacter pylori in Linqu County, China: baseline results and factors affecting the eradication. Gut. 2016;65(1):9-18. doi:10.1136/gutjnl-2015-309197

Source: PubMed

3
S'abonner